Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) >= ,/uL, obtained within  weeks prior to randomization
Peripheral absolute neutrophil count (ANC) >= /uL
Peripheral absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL (>= . X ^/L), within  days of registration
Absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Peripheral absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL, within  days of registration
Absolute neutrophil count (ANC) ? /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Peripheral absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) ? /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL performed within  days prior to the date of registration
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) ? ,/uL within  days prior to registration
Within  days prior to registration: Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL
INCLUSION - TREATMENT: Absolute neutrophil count (ANC) >/ul
Peripheral absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL.
Absolute neutrophil count (ANC) >= ,/uL within  days prior to first dose of protocol-indicated treatment.
Absolute neutrophil count (ANC) < ,/uL
Absolute neutrophil count (ANC) > ,/uL
Within  days prior to the start of study treatment: Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/mm^, performed within  days prior to day  of protocol therapy\r\n* Filgrastim can be given prior to enrollment to achieve target ANC >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Within  days prior to treatment start: Absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) > ,/uL.
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= . k/uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/ uL, within  weeks of registration
Peripheral absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= . x ^/L (>=  /uL)
Absolute neutrophil count (ANC) > /ul
Absolute neutrophil count (ANC) >=  ul
Absolute neutrophil count (ANC) >=  ul.
Absolute neutrophil count (ANC) > /uL
Absolute neutrophil count (ANC) >  K/uL.
ANC (Absolute neutrophil count) >= /ul (unsupported)
Absolute neutrophil count (ANC) . x ^/L (,/uL)
Absolute neutrophil count (ANC) > ,/uL unless disease-related (due to marrow infiltration or splenomegaly)
Absolute neutrophil count (ANC) >= ,/uL
Within  days prior to enrollment: Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) of >= ,/uL
Absolute neutrophil count (ANC) < /uL
Absolute neutrophil count (ANC) >= /ul within  days of cycle  day 
absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) > ,/uL
Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) >= ,/ uL, within  weeks of registration (except where specified otherwise)
Absolute neutrophil count (ANC) =< ,/uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /ul
Peripheral absolute neutrophil count (ANC) >= /uL
Within  days of registration: Absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) >= /uL; filgrastim can be given before and during treatment to achieve target ANC >=  uL
To be performed within  business days prior to day : Absolute neutrophil count (ANC) >= ,/mm^; filgrastim can be given prior to enrollment to achieve target ANC >= /uL
Absolute neutrophil count (ANC) >= ,/uL (performed within  days of registration)
Absolute neutrophil count (ANC) > /uL should be obtained within  days prior to enrollment
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL at screening visit
Absolute neutrophil count (ANC) > /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) or atypical glandular cell (AGC) >=  per uL
Peripheral absolute neutrophil count (ANC) >= ,/uL
Recovery from induction therapy (absolute neutrophil count [ANC] > /ul, platelet count > ,/ul)
Absolute neutrophil count (ANC) < /ul prior to treatment
Absolute neutrophil count (ANC) > /uL
Patients must have absolute neutrophil count (ANC) >= /uL; neupogen can be given before and during treatment to achieve target ANC >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) should be > /uL
Absolute neutrophil count (ANC) > /uL
Absolute neutrophil count (ANC) >= /uL
Within  days prior to study entry: Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) > ,/ul
Must be met within  days of CD: Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) of >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL, performed within  days prior to registration
Absolute neutrophil count (ANC) < /uL
Absolute neutrophil count (ANC) >= /uL
Peripheral absolute neutrophil count (ANC) ? /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) greater than /uL
Absolute neutrophil count (ANC) >= . x  ()uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) > ,/ul
Absolute neutrophil count (ANC) > /uL
Absolute neutrophil count (ANC) >=  uL
Absolute neutrophil count (ANC) > ,/uL
Absolute neutrophil count (ANC) >= , /uL
Absolute neutrophil count (ANC) >= /uL
Peripheral absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) =< /ul
Absolute neutrophil count (ANC) > ,/ul
Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) >= ,/ul within  days prior to starting treatment
Absolute neutrophil count (ANC) > ,/uL
Patients must have an absolute neutrophil count (ANC) > /ul and a platelet count > ,/ul
Absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) >= /ul
Peripheral absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL
Peripheral absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) > ,/uL
Patients must have absolute neutrophil count (ANC) > /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) => /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL, specimens must be collected within  days prior to the start of study treatment
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Peripheral absolute neutrophil count (ANC) > ,/uL
Absolute neutrophil count (ANC) >= /uL
Peripheral absolute neutrophil count (ANC) >= /uL\r\n* If the ANC and/or platelet count are not adequate, but due to bone marrow metastatic disease, these criteria will be waived
Absolute neutrophil count (ANC) >= /uL
Within  days of subject registration: Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) > ,/uL
Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) > /uL
Peripheral absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /ul
Peripheral absolute neutrophil count (ANC) >= /uL (must not have received filgrastim [G-CSF] within the prior  days)
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) > ,/ul
Absolute neutrophil count (ANC) > ,/ul
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) ? /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >=/microlitre (uL).
Absolute neutrophil count (ANC) > ,/uL
Peripheral absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) > /uL
Absolute neutrophil count (ANC) should be > /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) >  K/uL independent of transfusion support
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) > /uL
Within  weeks of administration of study therapy: Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >  uL
Absolute neutrophil count (ANC) > /ul
Absolute neutrophil count (ANC) < ,/ul
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Peripheral absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) > /uL
AT THE TIME OF INFUSION: Absolute neutrophil count (ANC) > /ul
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) >= /uL
COHORT A: Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /ul (unsupported)
Absolute neutrophil count (ANC) >=  / uL
Absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Peripheral absolute neutrophil count (ANC) >= /uL
Peripheral absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) =< /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) >= ,/ul (unless due to bone marrow infiltration by tumor in which case ANC >= /ml are allowed)
Absolute neutrophil count (ANC) < , /uL
Absolute neutrophil count (ANC) >= /uL
Peripheral absolute neutrophil count (ANC) >= ,/uL
Within  days after subjects signed the treatment consent: Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC): >= /uL (~  x ^/L)
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL
Patients must have an absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) >= /uL
Within  days prior to enrollment/randomization: Absolute neutrophil count (ANC) > . K/uL
Absolute neutrophil count (ANC) >= . K/uL
Absolute neutrophil count (ANC) >= ,/ul (unless low ANC is due to multiple myeloma)
Absolute neutrophil count (ANC) > /ul
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) > /ul
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) > ,/uL
Absolute neutrophil count (ANC): >= /uL (~. x ^/L)
Absolute neutrophil count (ANC) must be >= /uL
Absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC): >= ,/ul
Absolute neutrophil count (ANC) > ,/ ul 
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/ uL
Absolute neutrophil count (ANC) >= /uL
Peripheral absolute neutrophil count (ANC) >= /uL
Peripheral absolute neutrophil count (ANC) >= /uL
Absolute Neutrophil Count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/ul
Absolute neutrophil count (ANC) >= ,/ul
Peripheral absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /ul
Absolute neutrophil count (ANC) >= /uL
An absolute neutrophil count (ANC) > /ul
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) > /uL not supported by transfusions
Absolute neutrophil count (ANC) > . K/uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= /uL
Patients must have absolute neutrophil count (ANC) >= /uL; Neupogen can be given prior to start of SGN- (brentuximab vedotin) and during SGN- treatment to achieve target ANC >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) > /uL
Peripheral absolute neutrophil count (ANC) > ,/ul
Absolut neutrophil count (ANC) > /uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) > l/ul
Absolute neutrophil count (ANC) > /uL
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >=/uL
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) >= ,/uL
Patients with absolute neutrophil count (ANC) >= ,/uL; the most recent ANC level taken within  days prior to study enrollment will be considered
Have documented lab work with absolute neutrophil count (ANC) >= . K/uL and platelets >=  K/uL in the past  months
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) >= ,/uL
Peripheral absolute neutrophil (ANC) >= /uL
Absolute neutrophil count (ANC) > /ul
Absolute neutrophil count (ANC) >= /uL
Absolute neutrophil count (ANC) < , K/UL in the past  days
Absolute neutrophil count (ANC) greater than /uL
Absolute neutrophil count (ANC) < , K/UL in the past  days
Neutropenia (serum absolute neutrophil count [ANC] < ,/uL)
Absolute neutrophil count (ANC) >= ,/uL, obtained within  days prior to treatment start
Within  days of eligibility confirmation: Absolute neutrophil count (ANC) >= , uL
Absolute neutrophil count (ANC) ? /uL
Peripheral absolute neutrophil count (ANC) >= /uL (must not have received G-CSF [filgrastim] within the prior  days)
Absolute neutrophil count (ANC) >= ,/uL
Absolute neutrophil count (ANC) > /ul
Absolute neutrophil count (ANC) ? /uL
Absolute neutrophil count (ANC) ?/mm (?.  /uL)